INHIBIKASE THERAPEUTICS INC (IKT) Institutional Ownership Changes & 13F Activity

INHIBIKASE THERAPEUTICS INC (IKT). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Blackstone Inc., Kalehua Capital Management Llc, Millennium Management Llc, Citadel Advisors Llc, and Trails Edge Capital Partners, Lp.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Manufacturers Life Insurance Company, TheSell-1,719-6.0%27,054$54.92KQ2 2026Sep 09, 2026
Citadel Advisors LlcSell-1,028,236-93.3%74,349$150.93KQ2 2026Sep 02, 2026
California State Teachers Retirement SystemSell-4,382-74.5%1,501$3.05KQ2 2026Aug 24, 2026
Kalehua Capital Management LlcBuy+1,149,282+43.0%3,821,890$7.76MQ2 2026Aug 19, 2026
Mercer Global Advisors IncBuy+16,78116,781$34.06KQ2 2026Aug 19, 2026
Stonepine Capital Management, LlcSell-561,023-58.6%396,179$804.24KQ2 2026Aug 17, 2026
Seven Fleet Capital Management LpBuy+21,300+6.5%346,900$704.21KQ2 2026Aug 17, 2026
Blackstone Inc.Buy+5,938,2765,938,276$12.05MQ2 2026Aug 14, 2026
Millennium Management LlcBuy+1,100,025+37.6%4,028,102$8.18MQ2 2026Aug 14, 2026
Trails Edge Capital Partners, LpBuy+993,973+12.3%9,051,318$18.37MQ2 2026Aug 14, 2026
Adar1 Capital Management, LlcBuy+780,633+11.8%7,387,205$15.00MQ2 2026Aug 14, 2026
Sphera Funds Management Ltd.Buy+649,309649,309$1.32MQ2 2026Aug 14, 2026
Squadron Capital Management LlcSell-500,000-14.3%3,000,000$6.09MQ2 2026Aug 14, 2026
Aqr Capital Management LlcBuy+296,141+172.2%468,154$950.35KQ2 2026Aug 14, 2026
Summittx Capital, L.P.Buy+255,726+16.8%1,780,262$3.61MQ2 2026Aug 14, 2026
Bank Of America CorpSell-214,680-66.5%108,024$219.29KQ2 2026Aug 14, 2026
Goldman Sachs Group IncSell-99,687-66.5%50,170$101.84KQ2 2026Aug 14, 2026
Jones Financial Companies LllpBuy+96,291+299.0%128,491$245.42KQ2 2026Aug 14, 2026
Invesco Ltd.Buy+62,10362,103$126.07KQ2 2026Aug 14, 2026
Wells Fargo & Company/MnBuy+61,310+151.3%101,841$206.74KQ2 2026Aug 14, 2026
Price T Rowe Associates IncBuy+48,758+95.8%99,632$203.00KQ2 2026Aug 14, 2026
Two Sigma Investments, LpSell-41,347-4.9%806,264$1.64MQ2 2026Aug 14, 2026
Charles Schwab Investment Management IncBuy+39,627+16.8%275,041$558.33KQ2 2026Aug 14, 2026
Cerity Partners LlcBuy+38,01438,014$77.17KQ2 2026Aug 14, 2026
Susquehanna International Group, LlpSell-18,858-53.7%16,242$32.97KQ2 2026Aug 14, 2026
Squarepoint Ops LlcSell-18,135-58.5%12,854$26.09KQ2 2026Aug 14, 2026
Alliancebernstein L.P.Buy+15,32015,320$25.74KQ2 2026Aug 14, 2026
Royal Bank Of CanadaBuy+10,585+655.8%12,199$24.00KQ2 2026Aug 14, 2026
Mirae Asset Global Etfs Holdings Ltd.Buy+5,621+11.2%55,905$113.49KQ2 2026Aug 14, 2026
Saturn V Capital Management LpBuy+5,611+0.1%3,869,056$7.85MQ2 2026Aug 14, 2026
Showing 30 of 106

Frequently asked questions about IKT activity

  • Which institutional owners are buying IKT?

    Institutional owners buying IKT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in IKT activity?

    "Buy" means an investor increased their reported position in IKT compared to the prior reporting period. This reflects growing exposure to INHIBIKASE THERAPEUTICS INC (IKT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in IKT increasing?

    Institutional interest in IKT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.